Dasabuvir
Back to searchMolecule Structure
Scientific Name
Dasabuvir
Description of the Drug
Dasabuvir is a direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09183
http://www.drugbank.ca/drugs/DB09183
Brand Name(s)
Exviera
Company Owner(s)
Abbvie Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Hepatitis C virus NS5B RNA-dependent RNA polymerase | SINGLE PROTEIN | INHIBITOR | CHEMBL5375 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL351053 |
| PharmGKB | PA166163411 |
| Human Metabolome Database | HMDB0250872 |
| DrugBank | DB09183 |
| PubChem | 56640146 |
| LINCS | LSM-45402 |
| Nikkaji | J3.299.348F |
| DrugCentral | 4914 |
| ChemicalBook | CB62681991 |
| Guide to Pharmacology | 11270 |
| rxnorm | DASABUVIR |
| ChEBI | 85182 |
| ZINC | ZINC000095616937 |
